CD38 and plasma cell myeloma: Most publications on CD38 utilize CD38-targeted tracers for imaging of multiple myeloma, but CD38 was recently identified as a possible target for checkpoint inhibition [34], therefore CD38-targeted tracers might also find application in immunotherapy monitoring, but were not included in this review.